Click Here for 5% Off Your First Aladdin Purchase!

AMG 853 - ≥98%(HPLC), high purity , G protein-coupled receptor 44 antagonist, CAS No.1169483-24-2, G protein-coupled receptor 44 antagonist

  • Moligand™
  • ≥98%(HPLC)
Item Number
A286753
Grouped product items
SKUSizeAvailabilityPrice Qty
A286753-5mg
5mg
In stock
$166.90
A286753-10mg
10mg
In stock
$277.90
A286753-25mg
25mg
In stock
$625.90
A286753-50mg
50mg
In stock
$789.90
A286753-100mg
100mg
In stock
$1,251.90

Potent dual CRTH2 and prostaglandin D2(PGD2) receptor antagonist

Basic Description

SynonymsVIDUPIPRANT|1169483-24-2|AMG 853|AMG-853|2-(4-(4-(tert-butylcarbamoyl)-2-(2-chloro-4-cyclopropylphenylsulfonamido)phenoxy)-5-chloro-2-fluorophenyl)acetic acid|AMG 853(AMG853;Vidupiprant)|61OTZ32XNC|AMG853|CHEMBL1951575|2-[4-[4-(tert-butylcarbamoyl)-2-[(2-
Specifications & PurityMoligand™, ≥98%(HPLC)
Biochemical and Physiological MechanismsPotent prostaglandin D2(PGD2, CRTH2) receptor antagonist (IC50values are 8 and 35 nM, respectively in plasma). Inhibits PGD2-induced down modulation of CRTH2 on CD16-granulocytes in human whole blood as well as PGD2-induced cAMP response in platelets. Inh
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionG protein-coupled receptor 44 antagonist

Product Properties

ALogP6

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2D6 Tclin Cytochrome P450 2D6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C8 Tchem Cytochrome P450 2C8 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2J2 Tchem Cytochrome P450 2J2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C19 Tchem Cytochrome P450 2C19 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A7 Tclin Cytochrome P450 3A7 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2B6 Tchem Cytochrome P450 2B6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C9 Tchem Cytochrome P450 2C9 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2E1 Tchem Cytochrome P450 2E1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A5 Tclin Cytochrome P450 3A5 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT2B7 Tchem UDP-glucuronosyltransferase 2B7 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT2B15 Tbio UDP-glucuronosyltransferase 2B15 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A10 Tbio UDP-glucuronosyltransferase 1-10 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A1 Tchem UDP-glucuronosyltransferase 1-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A4 Tbio UDP-glucuronosyltransferase 1-4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A8 Tbio UDP-glucuronosyltransferase 1-8 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A9 Tbio UDP-glucuronosyltransferase 1-9 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGDR Tclin Prostaglandin D2 receptor 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGDR2 Tchem Prostaglandin D2 receptor 2 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CAPN1 Tchem Calpain-1 catalytic subunit 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A3 Tbio UDP-glucuronosyltransferase 1-3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A6 Tbio UDP-glucuronosyltransferase 1-6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT1A7 Tbio UDP-glucuronosyltransferase 1-7 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT2B4 Tbio UDP-glucuronosyltransferase 2B4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

UGT2B17 Tbio UDP-glucuronosyltransferase 2B17 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-[4-[4-(tert-butylcarbamoyl)-2-[(2-chloro-4-cyclopropylphenyl)sulfonylamino]phenoxy]-5-chloro-2-fluorophenyl]acetic acid
INCHI InChI=1S/C28H27Cl2FN2O6S/c1-28(2,3)32-27(36)17-6-8-23(39-24-14-21(31)18(11-19(24)29)13-26(34)35)22(12-17)33-40(37,38)25-9-7-16(10-20(25)30)15-4-5-15/h6-12,14-15,33H,4-5,13H2,1-3H3,(H,32,36)(H,34,35)
InChi Key PFWVGKROPKKEDW-UHFFFAOYSA-N
Canonical SMILES CC(C)(C)NC(=O)C1=CC(=C(C=C1)OC2=C(C=C(C(=C2)F)CC(=O)O)Cl)NS(=O)(=O)C3=C(C=C(C=C3)C4CC4)Cl
Isomeric SMILES CC(C)(C)NC(=O)C1=CC(=C(C=C1)OC2=C(C=C(C(=C2)F)CC(=O)O)Cl)NS(=O)(=O)C3=C(C=C(C=C3)C4CC4)Cl
PubChem CID 42641863
Molecular Weight 609.49

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
K2217140Certificate of AnalysisAug 22, 2022 A286753
K2217141Certificate of AnalysisAug 22, 2022 A286753
K2217142Certificate of AnalysisAug 22, 2022 A286753
K2217150Certificate of AnalysisAug 22, 2022 A286753
K2217151Certificate of AnalysisAug 22, 2022 A286753

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 60.95, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 60.95, Max Conc. mM: 100

Related Documents

References

1. Busse WW, Wenzel SE, Meltzer EO, Kerwin EM, Liu MC, Zhang N, Chon Y, Budelsky AL, Lin J, Lin SL.  (2013)  Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients..  J Allergy Clin Immunol,  131  (2): (339-45).  [PMID:23174659]
2. Liu J, Li AR, Wang Y, Johnson MG, Su Y, Shen W, Wang X, Lively S, Brown M, Lai S et al..  (2011)  Discovery of AMG 853, a CRTH2 and DP Dual Antagonist..  ACS Med Chem Lett,  (5): (326-30).  [PMID:24900313]

Solution Calculators